1. $SYN $ACOR $SNY $BIIB sorry rights to Trimesta

  2. $SYN I believe the 3 companies interested in the rights to SYN are $BIIB, $ACOR, and a mega pharma, probably $SNY, but room for error here

  3. $ACOR what s the news and why is it down today?

  4. Acorda Therapeutics given $30.00 PT by Canaccord Genuity. hold rating. http://www.analystratings.net/stocks/NASDAQ/ACOR/?RegistrationCode=SocialMedia-direct $ACOR

  5. Acorda: Item 8.01 Other Events http://www.conferencecalltranscripts.org/8/summary2/?id=1728237 $ACOR

  6. $ACOR: New SEC Filing for ACOR: Form 8-K, No. 0001140361-15-021787 http://stocknewsflow.com/1008848_000114036115021787_0001140361-15-021787

  7. $ACOR Acorda Therapeutics to Present at the Jefferies Global Healthcare Conference http://www.finances.com/company-news/98944-acorda-therapeutics-to-present-at-the-jefferies-global-healthcare-conference.htm

  8. $ACOR is rated BUY by Wall Street analysts with 37.3% upside based on averages of all analyst ratings/targets http://manyratings.com/ACOR

  9. $AMAG vs. $ACOR vs. $ARIA vs. $PDLI Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMAG|ACOR|ARIA|PDLI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  10. Top 10 Profitable BIOTECH #Stocks Ranked By LOWEST Price/Sales: Inc $PDLR $ACOR $MYGN $GILD $AMGN ++ http://www.tradepilot.com/screener/results#si=1401/t=mc:gt50m,av:gt30k/f=opm:gt0/s=f_psr:a

  11. $ACOR vs. $FGEN vs. $NLNK vs. $ARIA Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ACOR|FGEN|NLNK|ARIA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  12. Insider Transaction: $ACOR Sale at $30.16 per share of 475 shares by Officer Hindman Andrew A. on 2015-05-15.

  13. $ACOR vs. $ARIA vs. $PDLI vs. $NLNK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ACOR|ARIA|PDLI|NLNK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  14. $ACOR vs. $ARIA vs. $PDLI vs. $FGEN Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ACOR|ARIA|PDLI|FGEN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  15. $ACOR - ACOR indecision at support - https://www.tradingview.com/chart/ACOR/jSjMsiFK-ACOR-indecision-at-support/

  16. $ACOR ACOR indecision at support. acor sits at a support level of 28.5 where price shows indecision its now a mather of

  17. Parkinson s biotech Cynapsus Therapeutics files for a $60 million US IPO $CYNA $ACOR #Biotech $IPO #IPO http://www.renaissancecapital.com/news/parkinsons-biotech-cynapsus-therapeutics-files-for-a-%2460-million-us-ipo-31496.html?utm_source=dlvr.it&utm_medium=stocktwits

  18. Acorda Therapeutics Insider Andrew Hindman Sells $142,510 in $ACOR http://www.analystratings.net/stocks/NASDAQ/ACOR/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  19. $ACOR Acorda Therapeutics Inc (NASDAQ:ACOR) s Insider Andrew Hindman Sells 4,779 Shares http://www.octafinance.com/acorda-therapeutics-inc-

  20. Acorda Therapeutics given $30.00 PT by Canaccord Genuity. hold rating. http://www.analystratings.net/stocks/NASDAQ/ACOR/?RegistrationCode=SocialMedia-direct $ACOR

  21. $ACOR: New Insider Transaction on ACOR by Chief Business Dev. Officer Hindman Andrew A.: http://insideri.com/1607965_000120919115043432_0001209191-15-043432

  22. Acorda Therapeutics s Chief Business Dev. Officer just disposed of 4,779 shares http://www.conferencecalltranscripts.org/4/summary/?id=1706814 $ACOR

  23. Scan results - Bullish Engulfing today: $CSTM $GIL $WUBA $BCOR $LULU $ACOR $KANG $ETSY $YNDX ... http://swingtradebot.com/events/13/equities?selected_date=2015-05-14

  24. $SYN rumors swirling that Biogen may buyout $ACOR. If true, I think $BIIB and $SNY are the two players looking closely at Trimesta now.

  25. $SYN The giant pharm Riley mentioned has to be either Sanofi/Novartis/Merck. My guess is the other two are $BIIB and $ACOR.